(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 th and June 3 rd, 2025, was host to a biomarkers in kidney cancer session. Dr.

Biomarkers reveal vital insights that could improve treatment strategies for aggressive prostate cancer, offering hope for ...

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending ...

UC Davis Comprehensive Cancer Center is testing a drug called niraparib (ZEJULA), given before prostate cancer surgery.

Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...

An AI test boosts cure chances for prostate cancer by predicting who benefits from abiraterone, reducing side effects and ...

New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while ...

(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer session and a presentation by Dr. April Rose discussing a ctDNA–directed phase II study of carboplatin in patients with ...